Analyses Updated to 2022–23 on Australian Attitudes Towards Supervised Injecting Facilities
Corresponding Author
Zachary Lloyd
Burnet Institute, Melbourne, Australia
Correspondence:
Zachary Lloyd ([email protected])
Search for more papers by this authorSamantha Colledge-Frisby
Burnet Institute, Melbourne, Australia
National Drug Research Institute, Curtin University, Perth, Australia
National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, Australia
Search for more papers by this authorNicholas Taylor
Burnet Institute, Melbourne, Australia
National Drug Research Institute, Curtin University, Perth, Australia
Search for more papers by this authorMichael Livingston
Burnet Institute, Melbourne, Australia
National Drug Research Institute, Curtin University, Perth, Australia
Search for more papers by this authorMarianne Jauncey
National Drug Research Institute, Curtin University, Perth, Australia
Uniting Medically Supervised Injecting Centre, Sydney, Australia
Search for more papers by this authorAmanda Roxburgh
Burnet Institute, Melbourne, Australia
National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, Australia
Search for more papers by this authorCorresponding Author
Zachary Lloyd
Burnet Institute, Melbourne, Australia
Correspondence:
Zachary Lloyd ([email protected])
Search for more papers by this authorSamantha Colledge-Frisby
Burnet Institute, Melbourne, Australia
National Drug Research Institute, Curtin University, Perth, Australia
National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, Australia
Search for more papers by this authorNicholas Taylor
Burnet Institute, Melbourne, Australia
National Drug Research Institute, Curtin University, Perth, Australia
Search for more papers by this authorMichael Livingston
Burnet Institute, Melbourne, Australia
National Drug Research Institute, Curtin University, Perth, Australia
Search for more papers by this authorMarianne Jauncey
National Drug Research Institute, Curtin University, Perth, Australia
Uniting Medically Supervised Injecting Centre, Sydney, Australia
Search for more papers by this authorAmanda Roxburgh
Burnet Institute, Melbourne, Australia
National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, Australia
Search for more papers by this authorFunding: The authors received no specific funding for this work.
Open Research
Data Availability Statement
The data that support the findings of this study are available from Australian Institute of Health and Welfare. Restrictions apply to the availability of these data, which were used under license for this study. Data are available from https://ada.edu.au/national-drug-strategy-household-survey/ with the permission of Australian Institute of Health and Welfare.
References
- 1 Z. Lloyd, S. Colledge-Frisby, N. Taylor, M. Livingston, M. Jauncey, and A. Roxburgh, “Changes in Australians' Attitudes Towards Supervised Injecting Facilities,” Drug and Alcohol Review 43, no. 7 (2024): 1892–1904.
- 2 Uniting, “ Supporting for Uniting MSIC,” 2023, https://www.uniting.org/community-impact/uniting-medically-supervised-injecting-centre--msic/support-for-uniting-msic.
- 3 North Richmond Community Health, “ Medically Supervised Injecting Room,” 2023, https://nrch.com.au/services/medically-supervised-injecting-room/.
- 4 A. Roxburgh, M. Jauncey, C. A. Day, et al., “Adapting Harm Reduction Services During COVID-19: Lessons From the Supervised Injecting Facilities in Australia,” Harm Reduction Journal 18, no. 1 (2021): 20.
- 5 C. A. Day, A. M. Salmon, M. Jauncey, M. Bartlett, and A. Roxburgh, “Twenty-One Years at the Uniting Medically Supervised Injecting Centre, Sydney: Addressing the Remaining Questions,” Medical Journal of Australia 217, no. 8 (2022): 385–387.
- 6 A. Jefferson and M. Johnston. “ Angry Richmond Traders and Residents Say Heroin-Shooting Gallery is Not the Answer,” (2015), https://www.heraldsun.com.au/news/victoria/angry-richmond-traders-and-residents-say-heroinshooting-gallery-is-not-the-answer/news-story/4115f165883c821e0481bccc0b4ace19.
- 7 ABC. “ Herald Sun Says No. Media Watch,” (2021), https://www.abc.net.au/mediawatch/episodes/needle/13357230.
- 8 N. Wallis, “Why is the Heral Sun Obsessed with Medically Supervised Injection?,” AOD Media Watch (2021), https://www.aodmediawatch.com.au/herald-sun-obsessed-with-medically-supervised-injection/.
- 9 AOD Media Watch, “ AOD Media Watch,” (2025), https://www.aodmediawatch.com.au/.
- 10 J. McMaugh, “ Residents, Government and Health Experts Support Injection Rooms. Why Doesn't Television News? AOD Media Watch,” 2020, https://www.aodmediawatch.com.au/residents-government-and-health-experts-support-injection-rooms-why-doesnt-television-news/.
- 11 B. Whiteside and M. Dunn, “Voices Represented and Voices Silenced: Represented Voices in the Media Coverage of the Implementation of a Supervised Injecting Facility,” International Journal on Drug Policy 121 (2023): 104213.
- 12 R. Willingham and B. Rollason, “ Victorian Government Scraps Plans for a Second Supervised Injecting Room in Melbourne,” (2024), https://www.abc.net.au/news/2024-04-23/melbourne-cbd-safe-injecting-room-scrapped-drug-service/103756920s.
- 13 J. Hathaway-Wilson, “The Key Takeaways From NSW Drug Summit's Sydney Hearings,” ABC (2024), https://www.abc.net.au/news/2024-12-07/sydney-hearings-nsw-drug-summit-key-takeaways/104695668.
- 14 R. Morgan, “ National Drug Strategy Household Survey 2022 Technical Report,” 2023, https://dataverse.ada.edu.au/file.xhtml?fileId=18994&version=3.0.
- 15 C. Tebutt and J. B, “ Report on the 2024 New South Wales Drug Summit,” 2025 New South Wales.
- 16 NSW Government, “ Report on the Statutory Review of Part 2A of the Drug Misuse and Trafficking Act 1985 (NSW),” 2016 NSW.
- 17 A. Roxburgh and Z. Lloyd, “ Evidence Brief for Changes in Heroin Deaths in NSW,” 2024 Burnet Institute, Melbourne, Australia.
- 18 Coroners Court of Victoria, Victorian Overdose Deaths, 2013–2022 (Coroners Court of Victoria, 2024).
- 19 S. Z. F. Heard, J. A. Kwon, and L. Maher, “National Data Report 2023,” 2023 Sydney: Kirby Institute, UNSW Sydney.
- 20 J. Wojcicki, “Dying Alone: The Sad Irrelevance of Naloxone in the Context of Solitary Opiate Use,” Addiction 114, no. 3 (2019): 5740575.
